Jan Winter
Wiesenbach, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Genome scale CRISPR Cas9a knockout screen reveals genes that control glioblastoma susceptibility to the alkylating agent temozolomide.
Journal: All life
Published: August 22, 2022
NSUN6, an RNA methyltransferase of 5-mC controls glioblastoma response to temozolomide (TMZ) via NELFB and RPS6KB2 interaction.
Journal: Cancer biology & therapy
Published: October 27, 2021
Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 14, 2021
Genome-scale CRISPR screening at high sensitivity with an empirically designed sgRNA library.
Journal: BMC biology
Published: August 12, 2020
Ribosomal protein S11 influences glioma response to TOP2 poisons.
Journal: Oncogene
Published: June 11, 2019
Performance Evaluation of MHC Class-I Binding Prediction Tools Based on an Experimentally Validated MHC-Peptide Binding Data Set.
Journal: Cancer immunology research
Published: September 14, 2018
ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism.
Journal: Oncoimmunology
Published: April 19, 2017
GenomeCRISPR - a database for high-throughput CRISPR/Cas9 screens.
Journal: Nucleic acids research
Published: August 06, 2016
CRISPR library designer (CLD): software for multispecies design of single guide RNA libraries.
Journal: Genome biology
Published: December 21, 2015
caRpools: an R package for exploratory data analysis and documentation of pooled CRISPR/Cas9 screens.
Journal: Bioinformatics (Oxford, England)
Published: August 19, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026